HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study.

AbstractBACKGROUND:
Cardiovascular disease (CVD) is associated with a greater frailty risk, but it remains unknown if pathways that contribute to CVD are associated with the frailty risk. Thus, we aimed to investigate whether elevations in high-sensitivity cardiac troponin T (hs-cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) for those without known CVD at baseline are associated with a higher frailty risk.
METHODS:
This study used data from the Atherosclerosis Risk in Communities study. Cardiac biomarkers were measured from stored plasma samples collected at Visit 2 (1991-1993). Frailty was recorded at Visit 5 (2011-2013). Cox regression models were used to determine the association of cardiac biomarkers with frailty risk.
RESULTS:
Overall, 360/5199 (6.9%) participants aged 55.1 ± 5.1 years developed frailty during a median follow-up of 21.7 years. The incidence of frailty was significantly higher in participants with hs-cTnT ≥14 ng/L (vs. < 14 ng/L: 17.9% vs. 6.7%) or NT-proBNP ≥300 pg/ml (vs. < 300 pg/ml: 19.7% vs. 6.8%) (all P < 0.001). Comparing higher vs. lower cut-off levels of either hs-cTnT (14 ng/l) or NT-proBNP (300 pg/ml) demonstrated a greater than two-fold higher frailty risk, with hazard ratios (HRs) of 2.13 (95% confidence interval (CI): 1.130-4.01, P = 0.020) and 2.61 (95% CI: 1.28-5.33, P = 0.008), respectively. Individuals with both elevated hs-cTnT and NT-proBNP had a higher frailty risk than those without it (HR: 4.15; 95% CI: 1.50-11.48, P = 0.006).
CONCLUSIONS:
High hs-cTnT and NT-proBNP levels are strongly associated with incident frailty in the community-dwelling population without known CVD. Subclinical cardiac damage (hs-cTnT) and/or wall strain (NT-proBNP) may be the key pathway of CVD patients developing frailty. Detection of hs-cTnT and NT-proBNP may help for early screening of high-risk frailty and providing individualised intervention.
TRIAL REGISTRATION:
URL: https://www.
CLINICALTRIALS:
gov ; Unique identifier: NCT00005131 .
AuthorsYu Jia, Dongze Li, Jing Yu, Yi Liu, Fanghui Li, Wentao Li, Qin Zhang, Yongli Gao, Wei Zhang, Zhi Zeng, Rui Zeng, Xiaoyang Liao, Qian Zhao, Zhi Wan
JournalBMC geriatrics (BMC Geriatr) Vol. 22 Issue 1 Pg. 321 (04 12 2022) ISSN: 1471-2318 [Electronic] England
PMID35413794 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022. The Author(s).
Chemical References
  • Biomarkers
  • Peptide Fragments
  • Troponin T
  • Natriuretic Peptide, Brain
Topics
  • Atherosclerosis (diagnosis, epidemiology)
  • Biomarkers
  • Cardiovascular Diseases (diagnosis, epidemiology)
  • Frailty (complications, diagnosis, epidemiology)
  • Humans
  • Natriuretic Peptide, Brain
  • Peptide Fragments
  • Risk Factors
  • Troponin T

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: